global competitiveness

The January 2020 issue of Research!America's newsletter, The Research Advocate, is now online! In this issue: See the results of our latest survey conducted in partnership with members American Society for Human Genetics : Research!America-ASHG Survey Finds Americans Strongly Support Human Genetics Research . The survey finds the large majority of Americans agree genetic knowledge will be important to their own health and their families’ health. Americans also express great curiosity about genetics, as well as interest in what it tells us about human history and our common heritage as a species. Is the position of the U.S. in global science and engineering slipping ? Find out in the new...

Since Research!America was founded 30 years ago, a key strategy in advocating for medical and health research has been public opinion. As President Abraham Lincoln said, “…public sentiment is everything. With public sentiment, nothing can fail; without it nothing can succeed.” In this blog post series, we’ll highlight the findings of our 2019 national public opinion survey on medical, health, and scientific research, and explore the trends in the data where we can. U.S. Global Standing in Science and Innovation in 2050 Of significance, 62% do not have confidence that America's global preeminence will strengthen - they either responded with Statement B, neither or not sure. Research!America'...

Federal R&D Funding Remains ’€œWoefully Inadequate’€ to Address Health Threats and Global Competitiveness Highlights: Overall health R&D spending in the U.S. increased by $4.3 billion (3.5%). Industry, philanthropy and voluntary associations led gains in R&D spending. Federal R&D spending rose 2.2% but a considerable amount is the result of agency reorganization and reclassification. ALEXANDRIA, Va.’€” December 17, 2013 ’€” After declining in FY10-11, health-related research and development (R&D) spending in the U.S. increased by $4.3 billion (3.5%) in FY11-12, according to Truth and Consequences: Health R&D Spending in the U.S. (FY11-12), the 10th edition from...

by Mary Woolley, Research!America President and CEO. This entry was originally posted as a guest contribution to PhRMA’€™s Conversations forum. A shift in attitude among elected officials is necessary if this nation is to succeed in combating disease and stemming the rise of health care costs. Federal funding for the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and other agencies that conduct medical and health research has not kept pace with scientific opportunity, jeopardizing our ability to find cures for deadly disease and to maintain our global competitive edge. Medical research has not risen to the upper ranks of our nation’€™s priorities in the halls...